Increased plasma YKL-40 is associated with short-term survival in patients with cardiovascular disease and cancer. We tested the hypothesis that increased plasma YKL-40 is associated with total and disease-specific mortality in the general population.
Periodically we send out e-mail updates about YKL-40. If you would like to receive these, please enter your e-mail address on the right.
Print
E-mail